Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
ROS generation via photodynamic therapy is a therapeutic process whereby light-activated photosensitizers, in the presence of molecular oxygen, produce reactive oxygen species (notably singlet oxygen, superoxide, and hydroxyl radicals) within target tissues. These highly reactive, short-lived ROS induce rapid cell death by oxidation of membrane lipids, proteins, and nucleic acids, destroy tumor vasculature, and stimulate immune responses. ROS generation is essential for the efficacy of PDT and is not a single molecule or receptor, but rather a chemical outcome of the procedure. The location and intensity of ROS production depend on the distribution of the photosensitizer, light dosage, and tissue oxygenation. PDT effectiveness can be limited by tissue oxygen levels and light accessibility, and excessive ROS may pose risks of oxidative injury to healthy tissues.
Photoactivation of photosensitizers generates ROS which then induce cell death and immune activation in targeted tissues
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on Reactive oxygen species generation via photodynamic therapy (ROS generation via PDT (not universally standardized)).